ROBERT E. SOBOL, M.D.; DANIEL T. O'CONNOR, M.D.; JUDITH ADDISON, R.N.; KAREN SUCHOCKI, R.N.; IVOR ROYSTON, M.D.; LEONARD J. DEFTOS, M.D.
Serum chromogranin A concentrations measured by radioimmunoassay in patients with small-cell lung carcinoma were compared with values from healthy adults and patients with non-small-cell lung carcinoma or chronic obstructive pulmonary disease. The mean (± SE) level was significantly higher (p ≤ 0.02) in patients with smallcell lung carcinoma (815 ± 290 ng/mL, n= 46) than in normal controls (123 ± 6 ng/mL, n= 20) or patients with chronic obstructive pulmonary disease (169 ± 18 ng/mL, n= 39), lung adenocarcinoma (180 ± 22, ng/mL, n= 62), large-cell lung carcinoma (183 ± 23 ng/mL, n=18), or lung epidermoid carcinoma (203 ± 37 ng/mL, n= 78). The mean concentration in extensive-stage smallcell lung carcinoma (1155 ± 449 ng/mL, n= 29) was significantly greater (p=0.026) than in limited disease (234 ± 56 ng/mL, n=17). Elevated serum chromogranin A values were seen in 53% of patients with limited and 72% with extensive disease. Four patients originally classified as having non-small-cell lung carcinomas with raised chromogranin A levels were subsequently found to have mixed small-cell and non-small-cell tumors. Serum chromogranin A concentrations may be a useful marker of small-cell lung carcinoma disease activity.
SOBOL RE, O'CONNOR DT, ADDISON J, SUCHOCKI K, ROYSTON I, DEFTOS LJ. Elevated Serum Chromogranin A Concentrations in Small-Cell Lung Carcinoma. Ann Intern Med. ;105:698–700. doi: 10.7326/0003-4819-105-5-698
Download citation file:
Published: Ann Intern Med. 1986;105(5):698-700.
Hematology/Oncology, Lung Cancer, Pulmonary/Critical Care.
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use